Drug interaction between amprenavir and lopinavir/ritonavir in salvage therapy

被引:24
作者
Khanlou, H [1 ]
Graham, E
Brill, M
Farthing, C
机构
[1] AIDS Healthcare Fdn, Los Angeles, CA USA
[2] Vertex Pharmaceut, Cambridge, MA USA
关键词
D O I
10.1097/00002030-200203290-00018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:797 / 798
页数:2
相关论文
共 6 条
[1]   Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy [J].
Condra, JH ;
Petropoulos, CJ ;
Ziermann, R ;
Schleif, WA ;
Shivaprakash, M ;
Emini, EA .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :758-765
[2]  
DUVAL X, 2001, 2 INT WORKSH CLIN PH
[3]  
GATHE J, 11 S HIV INF TOUL FR
[4]  
HARRIS M, 2001, 1 IAS C HIV PATH TRE
[5]  
PEYTAVIN G, 2001, 2 INT WORKSH CLIN PH
[6]   Effect of reduced-dose amprenavir in combination with lopinavir on plasma levels of amprenavir in patients infected with HIV [J].
Stein, AJ ;
Brothers, CH ;
Scott, TR .
CLINICAL THERAPEUTICS, 2001, 23 (03) :513-515